Peptides DB
Research-centric peptide and protocol reference hub
Study 5 of 5Alexamorelin literatureChemistry (Weinheim an der Bergstrasse, Germany) · Review2026

Pd(II)-Catalyzed Strategies for the β-Arylation of α-Amino Acids: An Overview.

This review highlights Pd(II)-catalyzed strategies for β-arylation of α-amino acids, offering insights into peptide functionalization techniques.

Read at Chemistry (Weinheim an der Bergstrasse, Germany)Add to compare

Where it sits

this study against the rest of the alexamorelin corpus
0
Preclinical
3
Observational
0
Open-label
1
Randomised
1
Reviews · this one

Summary and findings

This mini-review discusses Pd(II)-catalyzed strategies for β-arylation of α-amino acids, focusing on C─H activation. It explores auxiliary bidentate directing groups and ligand-controlled processes. The review highlights recent developments in peptide late-stage functionalization.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
2026

Abstract

The authors’ words, as Chemistry (Weinheim an der Bergstrasse, Germany) supplied them

Metal-catalyzed C─H activation has been linked to amino acids for decades. Peptides and α -amino acids (α-AAs) have been used as substrates, directing groups (DGs) and ligands, significantly expanding and broadening the definition of metallo- and organo-catalysis. This mini-review focuses on strategies for β-arylation of α-AAs involving Pd(II)-mediated activation of the β-C(sp<sup>3</sup>)-H sigma bond. After a brief introduction in Section 1, strategies exploiting auxiliary bidentate DGs to address the Pd(II)-mediated C─H activation are discussed in Section 2. The related Ligand-controlled processes are treated in Section 3 and Section 4 highlight the most recent atom-economic developments in peptide late-stage functionalization (LSF) proceeding via Pd(II)-mediated β-C(sp<sup>3</sup>)-H activation of a precise α -AA residue along the peptide sequence.

Background

The paper addresses the chemical challenge of β-arylation in α-amino acids, which is significant for expanding the functionalization possibilities of peptides. Metal-catalyzed C─H activation has been a key area of research, and Pd(II) catalysis offers a promising route for these transformations. Understanding these strategies is crucial for advancing peptide chemistry and potential applications in drug development.

Methods

This is a mini-review summarizing existing literature on Pd(II)-catalyzed β-arylation of α-amino acids. It does not involve new experimental work but compiles strategies involving auxiliary bidentate directing groups and ligand-controlled processes. The review also discusses recent advances in peptide late-stage functionalization.

Results

Not reported in abstract.

Interpretation

The review provides a comprehensive overview of Pd(II)-catalyzed strategies for β-arylation, which is valuable for researchers in peptide chemistry. However, without new experimental data, the clinical or practical implications remain speculative. The strategies discussed could inform future experimental designs and applications in peptide modification.

Key findings

  • Pd(II)-mediated activation of β-C(sp3)-H sigma bond in α-amino acids.
  • Strategies using auxiliary bidentate directing groups for C─H activation.
  • Ligand-controlled processes for β-arylation of α-amino acids.
  • Recent developments in peptide late-stage functionalization via Pd(II) catalysis.

Limitations

  • No new experimental data presented.
  • Review format limits to summarizing existing strategies.
  • No quantitative findings or effect sizes reported.

Elsewhere in the Alexamorelin corpus

BIdentification of alexamorelin consumption biomarkers using human hepatocyte incubations and high-resolution mass spectrometry.Journal of analytical toxicology · 2025 · n=10 · Alexamorelin signal decreased approximately 150-fold after 3 h.In vitroDBurden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.Lancet (London, England) · 2025 · Total global DALYs grew 6.1% (95% UI 4.0-8.1), from 2.64 billion (2.46-2.86) in 2010 to 2.80 billion (2.57-3.08) in 2023.reviewBGlobal age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.Lancet (London, England) · 2025 · n=204 · 60.1 million deaths globally in 2023 (95% UI 59.0-61.1), n=204 countries.reviewAEffects of oral nutritional supplement on growth and body composition in malnutrition at risk and malnourished children: MARVEL study, a multi-center randomized controlled trial.European journal of nutrition · 2026 · n=159 · Weight gain: 0.16 kg (95% CI: 0.04-0.28) after 3 months, n=159.Human